Show simple item record

dc.contributor.authorKaul R.
dc.contributor.authorKimani J
dc.contributor.authorNagelkerke NJ.
dc.contributor.authorPlummer, FA
dc.contributor.authorBwayo, JJ
dc.contributor.authorBrunham RC.
dc.contributor.authorNgugi, Elizabeth N
dc.contributor.authorRonald, A
dc.date.accessioned2013-04-17T08:04:02Z
dc.date.available2013-04-17T08:04:02Z
dc.date.issued1997
dc.identifier.citationSex Transm Dis. 1997 Aug;24(7):387-92en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/9263358
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/16229
dc.description.abstractBACKGROUND AND OBJECTIVES: Genital ulcer disease (GUD) is a major risk factor for human immunodeficiency virus (HIV) transmission. Cross-sectional studies have suggested that HIV infection may itself predispose to genital ulceration (GU). GOAL: To prospectively study the effects of HIV type 1 (HIV-1) infection and behavioral variables on GU incidence. METHODS: A cohort of 302 Kenyan female sex-workers was established in April 1991. Women were scheduled for assessment every 2 weeks, and bloods were collected every 6 months for HIV serology, rapid plasma reagin (RPR) and CD4 counts. Logistic regression was used to study risk factors for incident genital ulcers. RESULTS: 189 women (62.5%) had at least one incident ulcer over 24.3 +/- 15.3 months. GU incidence was higher in seropositive than initially seronegative women (82% vs. 48%; odds ratio [OR]) = 4.33; P < 0.01). Only HIV-1 seropositivity (OR = 3.42), a CD4 count < 200/ml (OR = 1.94), and oral contraceptive use (OR = 1.35) were associated (P < 0.05) with GU incidence in regression analysis. For those ulcers where an etiology was actively sought, Hemophilus ducreyi was confirmed in 54 (19%) of cases, and syphilis in 30 (29%). CONCLUSION: GU incidence in Kenyan sex workers is independently affected by HIV-1 serostatus, degree of immunosuppression, and oral contraceptive use.en
dc.language.isoenen
dc.titleRisk factors for genital ulcerations in Kenyan sex workers. The role of human immunodeficiency virus type 1 infection.en
dc.typeArticleen
local.publisherDepartment of Medical Microbiology, University of Nairobi, Kenyaen
local.publisherDepartment of Medical Microbiology, University of Manitoba, Winnipeg, Canadaen
local.publisherDepartment of Community Health, University of Nairobi,en
local.publisherDepartmrnt of infectious Disease, University of Toronto, Canadaen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record